[Form 4] Flexsteel Industries Insider Trading Activity

Rhea-AI Filing Summary

Flexsteel Industries insider Stacy Marie Kammes, the company's Vice President of Human Resources, reported transactions on 08/22/2025. She was granted or received 5,655 shares (code A) at no cash price and sold 2,565 shares (code F) at $43.97 per share, leaving her with 28,346 shares beneficially owned after the reported transactions.

Positive

• Grant of 5,655 shares reported, indicating compensation or retention alignment with company incentives
• Disclosure filed and signed by attorney‑in‑fact, demonstrating compliance with Section 16 reporting requirements

Negative

• Sale of 2,565 shares at $43.97 reduced insider's holdings, indicating partial liquidation of shares

Insights

Financial Analyst

TL;DR: Insider received 5,655 shares and sold 2,565 shares, net increase in holdings but limited market impact.

The transactions show a non‑cash award or similar grant of 5,655 common shares (code A) and a contemporaneous sale of 2,565 shares at $43.97 (code F), resulting in 28,346 shares held. For a typical small‑cap issuer, these flows reflect routine insider compensation and liquidity activity rather than a material change to capital structure. No derivative transactions or amendments are reported.

Corporate Governance Expert

TL;DR: Transactions are consistent with executive compensation and routine insider selling; disclosure appears timely and complete.

The filing identifies the reporting person and relationship (VP, HR), the earliest transaction date of 08/22/2025, and is signed by an attorney‑in‑fact on 08/26/2025. The mix of an awarded grant (A) and a sale (F) is common for satisfying tax or diversification needs after a grant. The Form 4 shows no unexplained amendments or derivative positions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kammes Stacy Marie

(Last) (First) (Middle)

385 BELL ST

(Street)

DUBUQUE IA 52001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FLEXSTEEL INDUSTRIES INC [ FLXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP - Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		A		5,655	A	$0	30,911	D
Common Stock	08/22/2025		F		2,565	D	$43.97	28,346	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jennifer Zeman, attorney-in-fact	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for FLXS on this Form 4?

The filer received 5,655 shares (code A) and sold 2,565 shares (code F) at $43.97 per share on 08/22/2025.

Who filed the Form 4 for FLXS and what is their role?

The Form 4 was filed for Stacy Marie Kammes, listed as Vice President, Human Resources, and the filing was signed by an attorney‑in‑fact on 08/26/2025.

How many FLXS shares did the reporting person own after the transactions?

Following the reported transactions, the reporting person beneficially owned 28,346 shares.

Were any derivative securities reported in this Form 4 for FLXS?

No derivative securities are reported; Table II for derivatives contains no entries.

Does the Form 4 show any amendments or additional execution dates?

The form does not list an amendment date; the earliest transaction date is 08/22/2025 and no deemed execution date is provided.